Absence of Bim sensitizes mice to experimental Trypanosoma cruzi infection

[1]  S. Gea,et al.  Signaling pathways that regulate Trypanosoma cruzi infection and immune response. , 2020, Biochimica et biophysica acta. Molecular basis of disease.

[2]  A. Gruppi,et al.  Understanding CD8+ T Cell Immunity to Trypanosoma cruzi and How to Improve It. , 2019, Trends in parasitology.

[3]  L. Bavia,et al.  Chagas Disease: From Discovery to a Worldwide Health Problem , 2019, Front. Public Health.

[4]  E. Chatelain,et al.  Chagas Disease Treatment Efficacy Biomarkers: Myths and Realities , 2019, Chagas Disease.

[5]  A. Shibuya,et al.  Selective DNAM-1 expression on small peritoneal macrophages contributes to CD4+ T cell costimulation , 2018, Scientific Reports.

[6]  N. Putluri,et al.  Pentose Phosphate Shunt Modulates Reactive Oxygen Species and Nitric Oxide Production Controlling Trypanosoma cruzi in Macrophages , 2018, Front. Immunol..

[7]  I. Molina,et al.  Chagas disease , 2018, The Lancet.

[8]  C. Freire-de-Lima,et al.  Implication of Apoptosis for the Pathogenesis of Trypanosoma cruzi Infection , 2017, Front. Immunol..

[9]  N. Garg,et al.  Macrophages Promote Oxidative Metabolism To Drive Nitric Oxide Generation in Response to Trypanosoma cruzi , 2016, Infection and Immunity.

[10]  Ronit Vogt Sionov,et al.  Regulation of Bim in Health and Disease , 2015, Oncotarget.

[11]  K. Bortoluci,et al.  Revisiting Mouse Peritoneal Macrophages: Heterogeneity, Development, and Function , 2015, Front. Immunol..

[12]  N. Aguiló,et al.  Bim is a crucial regulator of apoptosis induced by Mycobacterium tuberculosis , 2014, Cell Death and Disease.

[13]  S. Epiphanio,et al.  Chagas Disease: Still Many Unsolved Issues , 2014, Mediators of inflammation.

[14]  G. Amarante-Mendes,et al.  In vivo assessment of specific cytotoxic T lymphocyte killing. , 2013, Methods.

[15]  L. Sardinha,et al.  Challenge of Chronically Infected Mice with Homologous Trypanosoma cruzi Parasites Enhances the Immune Response but Does Not Modify Cardiopathy: Implications for the Design of a Therapeutic Vaccine , 2012, Clinical and Vaccine Immunology.

[16]  E. Ghosn,et al.  Cellular Renewal and Improvement of Local Cell Effector Activity in Peritoneal Cavity in Response to Infectious Stimuli , 2011, PloS one.

[17]  D. Bartholomeu,et al.  The endless race between Trypanosoma cruzi and host immunity: lessons for and beyond Chagas disease , 2010, Expert Reviews in Molecular Medicine.

[18]  Leonore A. Herzenberg,et al.  Two physically, functionally, and developmentally distinct peritoneal macrophage subsets , 2010, Proceedings of the National Academy of Sciences.

[19]  L. Gonçalves,et al.  The Liver Plays a Major Role in Clearance and Destruction of Blood Trypomastigotes in Trypanosoma cruzi Chronically Infected Mice , 2010, PLoS neglected tropical diseases.

[20]  P. Choong,et al.  Bim-targeted cancer therapy: A link between drug action and underlying molecular changes , 2009, Molecular Cancer Therapeutics.

[21]  Y. Belkaid,et al.  Proapoptotic Bcl-2 Family Member Bim Promotes Persistent Infection and Limits Protective Immunity , 2007, Infection and Immunity.

[22]  A. Strasser.  The role of BH3-only proteins in the immune system , 2005, Nature Reviews Immunology.

[23]  R. Tarleton,et al.  Frequency of interferon- gamma -producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease. , 2004, The Journal of infectious diseases.

[24]  S. Boscardin,et al.  Immunization with cDNA Expressed by Amastigotes of Trypanosoma cruzi Elicits Protective Immune Response against Experimental Infection , 2003, Infection and Immunity.

[25]  A. Strasser,et al.  The Role of the Pro‐Apoptotic Bcl‐2 Family Member Bim in Physiological Cell Death , 2000, Annals of the New York Academy of Sciences.

[26]  C. Freire-de-Lima,et al.  The macrophage haunted by cell ghosts: a pathogen grows. , 2000, Immunology today.

[27]  H. Castro-Faria-Neto,et al.  Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages , 2000, Nature.

[28]  A. Strasser,et al.  Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. , 1999, Science.

[29]  F. Brombacher,et al.  Defective Nitric Oxide Effector Functions Lead to Extreme Susceptibility of Trypanosoma cruzi-Infected Mice Deficient in Gamma Interferon Receptor or Inducible Nitric Oxide Synthase , 1998, Infection and Immunity.

[30]  R. Tarleton,et al.  Amastigote surface proteins of Trypanosoma cruzi are targets for CD8+ CTL. , 1998, Journal of immunology.

[31]  F. Cunha,et al.  Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro , 1994, Infection and immunity.

[32]  T. Hirano,et al.  IL-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells. , 1988, Journal of immunology.

[33]  S. Reed.  In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections. , 1988, Journal of immunology.

[34]  H. Takehara,et al.  Role of the antibody Fc in the immune clearance of Trypanosoma cruzi. , 1988, Immunology letters.

[35]  R. Isturiz,et al.  Chagas Disease , 2021, Neglected Tropical Diseases.

[36]  C. Dolea,et al.  World Health Organization , 1949, International Organization.

[37]  Peter Griess,et al.  Bemerkungen zu der Abhandlung der HH. Weselsky und Benedikt „Ueber einige Azoverbindungen” , 1879 .